David A Denning, MD | |
1600 Medical Center Dr, Suite 2500, Huntington, WV 25701-3656 | |
(304) 691-1200 | |
(304) 691-1287 |
Full Name | David A Denning |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 47 Years |
Location | 1600 Medical Center Dr, Huntington, West Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982664694 | NPI | - | NPPES |
0128375000 | Medicaid | WV | |
0516865 | Medicaid | OH | |
64696388 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0102X | Surgery - Surgical Critical Care | 13046 (West Virginia) | Secondary |
208600000X | Surgery | 13046 (West Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Mary's Medical Center | Huntington, WV | Hospital |
Cabell Huntington Hospital Inc | Huntington, WV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Physicians And Surgeons, Inc | 2961315734 | 324 |
News Archive
Researchers at the Virginia Tech Carilion Research Institute have identified a naturally occurring molecule that has the potential for preserving sites of communication between nerves and muscles in amyotrophic lateral sclerosis (ALS) and over the course of aging - as well as a molecule that interferes with this helpful process.
A second look ultrasound of the breast, used in conjunction with MRI, allows radiologists to identify lesions not detected on conventional mammography and first look ultrasound; in some cases it allows radiologists to determine whether or not a lesion is malignant or benign, according to a study performed at the University of Rome La Sapienza in Rome, Italy.
Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).
Cancer Research UK today predicts a huge drop in deaths from bowel cancer if people use the self testing kit that is being sent to men and women in their sixties throughout the country.
When Spire Harpenden needed to increase its facilities in response to the ever-growing number of patients choosing the hospital for surgery, it approached KARL STORZ for its market-leading OR1 NEO® integrated operating theatre, specifically designed for minimally invasive surgery.
› Verified 5 days ago
Entity Name | University Physicians & Surgeons, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1730183286 PECOS PAC ID: 2961315734 Enrollment ID: O20031107000331 |
News Archive
Researchers at the Virginia Tech Carilion Research Institute have identified a naturally occurring molecule that has the potential for preserving sites of communication between nerves and muscles in amyotrophic lateral sclerosis (ALS) and over the course of aging - as well as a molecule that interferes with this helpful process.
A second look ultrasound of the breast, used in conjunction with MRI, allows radiologists to identify lesions not detected on conventional mammography and first look ultrasound; in some cases it allows radiologists to determine whether or not a lesion is malignant or benign, according to a study performed at the University of Rome La Sapienza in Rome, Italy.
Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).
Cancer Research UK today predicts a huge drop in deaths from bowel cancer if people use the self testing kit that is being sent to men and women in their sixties throughout the country.
When Spire Harpenden needed to increase its facilities in response to the ever-growing number of patients choosing the hospital for surgery, it approached KARL STORZ for its market-leading OR1 NEO® integrated operating theatre, specifically designed for minimally invasive surgery.
› Verified 5 days ago
Entity Name | Point Pleasant Physician Billing Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396798898 PECOS PAC ID: 3375538184 Enrollment ID: O20040419001780 |
News Archive
Researchers at the Virginia Tech Carilion Research Institute have identified a naturally occurring molecule that has the potential for preserving sites of communication between nerves and muscles in amyotrophic lateral sclerosis (ALS) and over the course of aging - as well as a molecule that interferes with this helpful process.
A second look ultrasound of the breast, used in conjunction with MRI, allows radiologists to identify lesions not detected on conventional mammography and first look ultrasound; in some cases it allows radiologists to determine whether or not a lesion is malignant or benign, according to a study performed at the University of Rome La Sapienza in Rome, Italy.
Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).
Cancer Research UK today predicts a huge drop in deaths from bowel cancer if people use the self testing kit that is being sent to men and women in their sixties throughout the country.
When Spire Harpenden needed to increase its facilities in response to the ever-growing number of patients choosing the hospital for surgery, it approached KARL STORZ for its market-leading OR1 NEO® integrated operating theatre, specifically designed for minimally invasive surgery.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
David A Denning, MD 1600 Medical Center Dr, Suite 2500, Huntington, WV 25701-3656 Ph: (304) 691-1200 | David A Denning, MD 1600 Medical Center Dr, Suite 2500, Huntington, WV 25701-3656 Ph: (304) 691-1200 |
News Archive
Researchers at the Virginia Tech Carilion Research Institute have identified a naturally occurring molecule that has the potential for preserving sites of communication between nerves and muscles in amyotrophic lateral sclerosis (ALS) and over the course of aging - as well as a molecule that interferes with this helpful process.
A second look ultrasound of the breast, used in conjunction with MRI, allows radiologists to identify lesions not detected on conventional mammography and first look ultrasound; in some cases it allows radiologists to determine whether or not a lesion is malignant or benign, according to a study performed at the University of Rome La Sapienza in Rome, Italy.
Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).
Cancer Research UK today predicts a huge drop in deaths from bowel cancer if people use the self testing kit that is being sent to men and women in their sixties throughout the country.
When Spire Harpenden needed to increase its facilities in response to the ever-growing number of patients choosing the hospital for surgery, it approached KARL STORZ for its market-leading OR1 NEO® integrated operating theatre, specifically designed for minimally invasive surgery.
› Verified 5 days ago
John T Walker, MD Surgery Medicare: Medicare Enrolled Practice Location: 1600 Medical Center Dr, Suite 2500, Huntington, WV 25701 Phone: 304-691-1200 Fax: 304-691-1287 | |
Onyechi Megafu, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 1st Ave Ste 210, Huntington, WV 25702 Phone: 304-525-7246 Fax: 304-526-1951 | |
Dr. Diane Marie Krutzler-berry, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Hal Greer Blvd, Huntington, WV 25701 Phone: 304-399-6610 Fax: 304-399-6621 | |
Timothy D.w. Canterbury, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1600 Medical Center Dr, Suite 2500, Huntington, WV 25701 Phone: 304-691-1200 Fax: 304-691-1287 | |
Subrat K Lahiry, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Center Dr, Suite 2500, Huntington, WV 25701 Phone: 304-691-1200 Fax: 304-691-1287 | |
Dr. Nepal C. Chowdhury, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2828 1st Ave, Suite 200, Huntington, WV 25702 Phone: 304-399-7530 Fax: 304-399-7532 | |
Errington Thompson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Center Dr Ste 2500, Huntington, WV 25701 Phone: 304-691-1200 Fax: 304-691-1287 |